首页/数据集/Solubility studies of HIPs of TOB with DOC at molar ratio of 1:5 in different SEDDS excipients.

Solubility studies of HIPs of TOB with DOC at molar ratio of 1:5 in different SEDDS excipients.

Figshare2023-06-09 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/Solubility_studies_of_HIPs_of_TOB_with_DOC_at_molar_ratio_of_1_5_in_different_SEDDS_excipients_/23469603 数据链接链接失效反馈

官方服务：

资源简介：

Solubility studies of HIPs of TOB with DOC at molar ratio of 1:5 in different SEDDS excipients.

应用场景：

创建时间：

2023-06-09

药物递送系统

体内研究

Given the extensive first pass metabolism of rizatriptan in oral administration and its delayed absorption during a migraine attack as a result of gastric stasis, focus has been on transdermal deliver

DataCite Commons2024-08-19 更新370

Developing a Copper(II) Agent Based on His-146 and His-242 Residues of Human Serum Albumin Nanoparticles: Integration To Overcome Cisplatin Resistance and Inhibit the Metastasis of Nonsmall Cell Lung Cancer

非小细胞肺癌治疗

药物递送系统

To overcome the resistance of nonsmall cell lung cancer (NSCLC) cells to cisplatin and inhibit their metastasis, we proposed to develop a Cu(II) agent based on the specific residue(s) of HSA nanopart

NIAID Data Ecosystem70

GNPS - Associating chitosan and microemulsion for intravaginal administration of herbal medicines in topical candidiasis treatment

药物递送系统

妇科感染治疗

In this work, we explore the association of chitosan in O/W microemulsions to produce potential mucoadhesive vehicles for the administration of herbal medicines. These bioactive have potential previou

NIAID Data Ecosystem40

A sulfonated reversible thermal gel for the spatiotemporal control of VEGF delivery to promote therapeutic angiogenesis

药物递送系统

血管生成治疗

Despite medical and surgical advancements for the treatment of cardiovascular disease, mortality and morbidity remain high. Therapeutic angiogenesis has been one approach to address the major clinical

doi.org120

Data set for Longitudinal pharmacokinetic and safety studies of an antibody-erythropoietin fusion protein for Alzheimer’s disease.

药物递送系统

阿尔茨海默病临床试验

Erythropoietin (EPO) is a promising Alzheimer's disease (AD) therapeutic but suffers from poor brain penetration, requiring high doses that cause hematopoietic side effects. This study evaluated a tra

NIAID Data Ecosystem60

Solubility studies of HIPs of TOB with DOC at molar ratio of 1:5 in different SEDDS excipients.

资源简介：

相关数据集